Zhejiang East-Asia Pharmaceutical (SH:605177) Xin Lang Zheng Quan·2025-11-03 05:14Group 1 - The core viewpoint of the news is that Dongya Pharmaceutical has shown a positive stock performance recently, with a 5.89% increase in stock price year-to-date and a 3.99% increase over the last five trading days [1] - As of November 3, the stock price reached 20.86 yuan per share, with a market capitalization of 2.393 billion yuan [1] - The company reported a net inflow of main funds amounting to 2.6794 million yuan, indicating investor interest [1] Group 2 - Dongya Pharmaceutical's revenue for the first nine months of 2025 was 596 million yuan, a decrease of 38.08% year-on-year, while the net profit attributable to shareholders was -72.41 million yuan, a decline of 260.31% [2] - The company has distributed a total of 132 million yuan in dividends since its A-share listing, with 69.72 million yuan distributed over the past three years [3] - As of September 30, 2025, the number of shareholders increased by 2.48% to 10,900, while the average number of tradable shares per person decreased by 2.42% to 10,298 shares [2]